Loading…

Effects of high‐intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial

BACKGROUND Testicular cancer survivors (TCS) have an increased risk of treatment‐related cardiovascular disease (CVD), which may limit their overall survival. We evaluated the effects of high‐intensity aerobic interval training (HIIT) on traditional and novel CVD risk factors and surrogate markers o...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2017-10, Vol.123 (20), p.4057-4065
Main Authors: Adams, Scott C., DeLorey, Darren S., Davenport, Margie H., Stickland, Michael K., Fairey, Adrian S., North, Scott, Szczotka, Alexander, Courneya, Kerry S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Testicular cancer survivors (TCS) have an increased risk of treatment‐related cardiovascular disease (CVD), which may limit their overall survival. We evaluated the effects of high‐intensity aerobic interval training (HIIT) on traditional and novel CVD risk factors and surrogate markers of mortality in a population‐based sample of TCS. METHODS This phase 2 trial (ClinicalTrials.gov identifier NCT02459132) randomly assigned 63 TCS to usual care (UC) or 12 weeks of supervised HIIT (ie, alternating periods of vigorous‐intensity and light‐intensity aerobic exercise). The primary outcome was peak aerobic fitness (VO2peak) assessed via a treadmill‐based maximal cardiorespiratory exercise test. Secondary endpoints included CVD risk (eg, Framingham Risk Score), arterial health, parasympathetic nervous system function, and blood‐based biomarkers. RESULTS Postintervention VO2peak data were obtained for 61 participants (97%). HIIT participants attended 99% of the exercise sessions and achieved 98% of the target exercise intensity. Analysis of covariance demonstrated that HIIT was superior to UC for improving VO2peak (adjusted between‐group mean difference, 3.7 mL O2/kg/min; 95% confidence interval, 2.4‐5.1 [P
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.30859